The life sciences industry has been challenged over the last several years with an economic environment that is not conducive to breeding new innovation. While things are slowly improving, reports abound of fewer investments in life science start-ups and fewer active investors in the sector. Many new ideas aren’t being developed—because the financial climate can’t … Continue reading “Big Pharma’s Role in Supporting the Life Science Innovation Ecosystem”
Author: Diego Miralles
Diego Miralles leads Janssen Healthcare Innovation, an entrepreneurial team in the Janssen Pharmaceutical Companies of Johnson & Johnson. With a background of over 13 years in the healthcare industry and 12 years in the hospital and academic worlds, Miralles has had many significant leadership roles, including head of Johnson & Johnson’s Pharmaceutical Research and Development West Coast Research Center in La Jolla, CA. Miralles has extensive experience in clinical research, mostly in HIV/AIDS, including work on antiviral drug development at Belgium’s Tibotec BVBA, Trimeris, Inc, and Triangle Pharmaceuticals. He currently serves as an adjunct full professor in the pharmacology department at the University of California, San Diego, and is on the Board of the Rady Children’s Hospital. He was previously on the faculty at Duke University, Durham, NC, where he had a clinical HIV practice, and served as the attending physician in charge at The AIDS Clinical Trial Unit, Beth Israel Medical Center, NY. He completed his fellowship in Infectious Diseases at Cornell University-New York Hospital after a residency in Internal Medicine at the Mayo Clinic in Rochester, MN. He graduated from the University Of Buenos Aires School Of Medicine in 1986.